| CROSSJECT SA EO -,10 |
| Frankreich |
| Gesundheit |
| FR0011716265 / A1XEH4 |
| 74C (Frankfurt) |
| FRA:74C, ETR:74C, 74C:GR |
| - |
| https://www.crossject.com.. |
|
Crossject S.A. is a pharmaceutical company specializing in the development of needle-free, pre-filled delivery systems known as Zeneo injectors. Its primary function is to provide a pain-free, user-friendly alternative to traditional hypodermic injec..
>Volltext.. |
| 109.59 Mio. EUR |
| 124.33 Mio. EUR |
| - |
| 3.8 Mio. EUR |
| -10.55 Mio. EUR |
| -0.21 EUR |
| 20.16 Mio. EUR |
| 5.17 Mio. EUR |
| - |
| 0.77 |
| - |
| 18.98% |
| - |
| - |
| - |
| - |
| CROSSJECT |
| 05.04.26 |
|